Barcelona, Spain

Francisco Javier Luque Garriga


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francisco Javier Luque Garriga: Innovator in Neuroprotective Compounds

Introduction

Francisco Javier Luque Garriga is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of neuroprotective compounds, particularly in the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's. His innovative work has led to the development of a unique compound that holds promise for therapeutic applications.

Latest Patents

Luque Garriga holds a patent for "Derivatives of propargylamine having neuroprotective capacity for the treatment of Alzheimer's and Parkinson's diseases." This invention relates to a compound of formula (I), which includes various chemical structures designed to provide neuroprotective effects. The patent outlines the procedure for obtaining these compounds, their pharmaceutical compositions, and their use in treating neurodegenerative diseases.

Career Highlights

Throughout his career, Francisco Javier Luque Garriga has worked with esteemed institutions such as the Consejo Superior de Investigaciones Científicas and the Universitat Autònoma de Barcelona. His research has focused on developing innovative solutions to combat neurodegenerative disorders, showcasing his commitment to advancing medical science.

Collaborations

Luque Garriga has collaborated with notable colleagues, including Abdelouahid Samadi and José Luis Marco Contelles. These partnerships have contributed to the success of his research and the development of his patented compounds.

Conclusion

Francisco Javier Luque Garriga is a distinguished inventor whose work in neuroprotective compounds has the potential to impact the treatment of Alzheimer's and Parkinson's diseases significantly. His contributions to the field highlight the importance of innovation in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…